Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study
Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study
The overall goal of the proposed research is to evaluate the uptake of testing and
 longitudinal risks and benefits of multiplex testing for cancer susceptibility in BRCA1/2
 negative patients. This model will inform the selection of the outcomes and potential
 mediators and moderators of these outcomes, to inform the debate over utility, risks, and
 benefits of clinical incorporation of multiplex testing for breast cancer susceptibility.
Inclusion Criteria:

 -  1. Women and men (at least 18 YO) 2. English speaking AND 3. Negative for BRCA1 and
 BRCA2 mutations

 Exclusion Criteria:

 1. Non English speaking patients